AD/HD diagnosis through EEG, a pilot study

Mentis Cura ehf.0 个研究点目标入组 80 人开始时间: 2006年8月3日最近更新: 2016年10月17日

适应症

试验速览

暂无简介。

•Healthy subjects:
•–Between 6-8 years of age
•–On the parent-completed SDQ, scores on the four proplem subscales (Hyperactivity, Emotional Problems, Conduct Problems, Peer Problems) should not exceed 1.0 standard deviation above the age appropriate mean. On the AD/HD Rating scale-IV, Inattention and Hyperactivity subscores should not exceed one standard deviation above the mean. The means and standard deviations mentioned here refer to Icelandic norms.
•AD/HD subjects:
•–Between 6-8 years of age
•–Recently diagnosed with AD/HD according to DSM-IV
•–Other possibilities have been exhausted and treatment using methylphenidate (Ritalin®) is the only viable option left
•Are the trial subjects under 18? yes
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) no
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•–Individual has Tourette syndrome
•–Individual suffers from psychosis
•–Individual suffers from mental retardation
•–Individual allergic to the investigational material
•–Individual is receiving treatment for other diseases affecting the central nervous system
•–Hypersensitivity to methylphenidate or any other component in the Ritalin® formulation
•–Participation in another investigational study at the same time

发起方